Based on the Achieve Life Sciences Inc stock forecast from 3 analysts, the average analyst target price for Achieve Life Sciences Inc is USD 16.75 over the next 12 months. Achieve Life Sciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Achieve Life Sciences Inc is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Achieve Life Sciences Inc’s stock price was USD 4.54. Achieve Life Sciences Inc’s stock price has changed by -0.66% over the past week, -1.30% over the past month and -43.81% over the last year.
No recent analyst target price found for Achieve Life Sciences Inc
No recent average analyst rating found for Achieve Life Sciences Inc
Company Overview Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada. Address: 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1 Read Less
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interac...Read More
Frequently Asked Questions About Achieve Life Sciences Inc (ACHV) Stock
Based on ratings from 3 analysts Achieve Life Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on ACHV's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for ACHV is USD 16.75 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 11.
ACHV stock's Price/Earning ratio is 2.80.
Our analysis grades ACHV stock's Price / Earning ratio at D-. This means that ACHV stock's Price/Earning ratio is above 39% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this ACHV may be fairly valued for its sector
The last closing price of ACHV's stock was USD 4.54.
The most recent market capitalization for ACHV is USD 0.15B.
Based on targets from 3 analysts, the average taret price for ACHV is projected at USD 16.75 over the next 12 months.
This means that ACHV's stock price may go up by +268.94% over the next 12 months.
We can't find any ETFs which contains Achieve Life Sciences Inc's stock.
As per our most recent records Achieve Life Sciences Inc has 22 Employees.
Achieve Life Sciences Inc's registered address is 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1.
You can get more information about it from Achieve Life Sciences Inc's website at https://www.achievelifesciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ACHV !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
